The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine how medications thought to attenuate the effects of
alcohol (naltrexone) and smoking cessation medications (varenicline) affect the ability to
resist smoking and also subsequent ad-lib smoking, following a low-dose alcohol priming
drink, in non-treatment seeking alcohol-drinking daily smokers.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)